25.11.2022

Reports of suspected adverse reactions to COVID-19 vaccines

16,212 reports of suspected adverse vaccination reactions evaluated

22.11.2022

Vigilance-News Edition 29

In this edition: Reports of urticaria after booster vaccination with Spikevax; Contrast-induced neurotoxicity; Swiss Haemovigilance System: Regulatory aspects and transfusion reactions; Statistical Review 2021: Pharmacovigilance for human medicinal products, vaccinovigilance, vigilance for veterinary medicinal products

22.11.2022

Vigilance-News Edition 29

In this edition: Reports of urticaria after booster vaccination with Spikevax; Contrast-induced neurotoxicity; Swiss Haemovigilance System: Regulatory aspects and transfusion reactions; Statistical Review 2021: Pharmacovigilance for human medicinal products, vaccinovigilance, vigilance for veterinary medicinal products

21.11.2022

Access Consortium Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition

Access Consortium commits to demonstrate greater inspection reliance and accept GMP inspection outcomes held amongst their members

18.11.2022

Moderna applies to Swissmedic for authorisation of a second bivalent COVID-19 vaccine

Application submitted for Spikevax Bivalent Original / Omicron BA.4-5 (mRNA-1273.222)

18.11.2022

The latest issue of “Visible” is here!

In the sixth issue of Swissmedic’s “Visible” magazine, we introduce our apprentices and give insights into Swissmedic's collaboration with patient and consumer organisations – and much more! We hope you enjoy reading it!

In focus

Covid-19-Fokus

COVID-19 Pandemic

Information on the new coronavirus (SARS-CoV-2)
 

Vaccines against COVID-19

20 years Swissmedic

Anniversary message from the Director

Happy Birthday Swissmedic

Contact for members of the public

Do you have any questions about a particular medicine or a general question about Swissmedic? We’ll be glad to be of assistance. 

Just send an e-mail to anfragen@swissmedic.ch or use our contact form. Thank you.

Direct links


Stay up to date


Reporting undesirable effects and incidents

Medicines


Medical devices

Swiss Public Assessment Report (SwissPAR)

SwissPAR

Public Summary SwissPAR

Featured


Swissmedic video portrait

Swissmedic monitors all therapeutic products on the market in Switzerland. Our independent experts ensure the therapeutic products you and your loved ones need are effective, safe and of the highest quality.

Illegal medicinal products from the Internet

Find out in this video why you should be careful when buying medicinal products online, and what happens if customs officials discover that a consignment addressed to you contains illegally imported medicinal products.

Medizinprodukte

30.05.2022

New medical devices regulations

Information concerning the new EU-Regulations as well as their implementation in Switzerland.

swissmedic-teaser-mep-video1-anim

What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.


Swissmedic, Swiss Agency for Therapeutic Products

swissmedic_hauptsitz-hallerstrasse7-bern_03

Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...
https://www.swissmedic.ch/content/swissmedic/en/home.html